Novasep to Invest $7.6 million to Expand API Manufacturing Workshop Capacity

November 11, 2020
Pharmaceutical Technology Editors

Construction on the workshop is currently underway with plans for it to be fully operational by the end of 2021.

Novasep announced on Nov. 10, 2020 that it is investing EUR 6.5 million (US$7.6 million) to expand capacity for the API manufacturing workshop at its Chasse-sur-Rhône, France, site.

The expanded workshop will include two synthesis reactors (4000L Hastelloy & 1600L glass lined) for low to medium volume APIs that include a high-performance thermal system and a high level of automation, a company press release said. The investment will also include the repositioning of the workshop’s high-pressure hydrogenation reactor (1500L,15bar) to a new area in the space.

Construction on the workshop is currently underway with plans for it to be fully operational by the end of 2021, according to the company press release.

"Upgrading this workshop with the addition of two new reactors will enable us to continue modernizing our Chasse-sur-Rhône site's API manufacturing facilities, whilst improving flexibility and productivity,” said Jean Bléhaut, president of the Synthesis Solutions Business Unit of Novasep, in the press release. "These investments will also reduce our environmental impact by optimizing energy consumption. This is an opportunity for us to respond to social and environmental challenges using technological advances.”

Source: Novasep